Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China · Delayed Price · Currency is CNY 8.44
-0.19 (-2.20%)
Jul 30, 2026, 3:00 PM CST
SHA:603520 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 308.01 | 415.34 | 603.35 | 565.13 | 661.56 | 775.74 |
Trading Asset Securities | - | - | - | 0.02 | 0.88 | 70.16 |
Cash & Short-Term Investments | 308.01 | 415.34 | 603.35 | 565.16 | 662.44 | 845.9 |
Cash Growth | -25.13% | -31.16% | 6.76% | -14.69% | -21.69% | -9.07% |
Accounts Receivable | 802.06 | 567.92 | 437.16 | 492.44 | 711.18 | 663.79 |
Other Receivables | 4.96 | 6.27 | 4.27 | 4.82 | 8.31 | 12.77 |
Receivables | 807.02 | 574.2 | 441.42 | 497.26 | 719.49 | 676.56 |
Inventory | 1,145 | 1,192 | 1,105 | 1,148 | 738.58 | 517.59 |
Other Current Assets | 113.95 | 90.2 | 80.77 | 54.07 | 51.12 | 21.76 |
Total Current Assets | 2,374 | 2,272 | 2,231 | 2,265 | 2,172 | 2,062 |
Property, Plant & Equipment | 3,011 | 2,989 | 2,866 | 2,345 | 2,189 | 1,791 |
Long-Term Investments | 130.6 | 131.07 | 156.13 | 129.42 | 135.94 | 159.55 |
Goodwill | 404.96 | 404.96 | 404.96 | 404.96 | 404.96 | 519.71 |
Other Intangible Assets | 285.65 | 289.46 | 302.55 | 311.93 | 310.73 | 231.17 |
Long-Term Deferred Tax Assets | 37.05 | 43.76 | 36.96 | 21.72 | 22.5 | 14.39 |
Long-Term Deferred Charges | 7.77 | 7.84 | 13.52 | 19.23 | 39.05 | 41.18 |
Other Long-Term Assets | 23.7 | 17.23 | 34.92 | 19.14 | 28.62 | 77.03 |
Total Assets | 6,274 | 6,155 | 6,046 | 5,516 | 5,302 | 4,895 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 407.99 | 374.42 | 532.86 | 508.1 | 540.63 | 590.94 |
Accrued Expenses | 22.91 | 94.42 | 93.76 | 72.52 | 58.27 | 57.4 |
Short-Term Debt | 1,404 | 1,634 | 1,441 | 1,855 | 1,689 | 926.92 |
Current Portion of Long-Term Debt | 393.17 | 250.03 | 545.02 | 465.23 | 416.29 | 232.75 |
Current Portion of Leases | - | 56.3 | 41.45 | 1.7 | 1.56 | 1.56 |
Current Income Taxes Payable | 21.49 | - | 7.16 | 0.71 | 0.73 | 28.03 |
Current Unearned Revenue | 2.57 | 5.77 | 4.45 | 10.92 | 10.44 | 5.1 |
Other Current Liabilities | 68.31 | 22.32 | 12.06 | 17.19 | 43.07 | 43.35 |
Total Current Liabilities | 2,320 | 2,437 | 2,677 | 2,931 | 2,760 | 1,886 |
Long-Term Debt | 1,170 | 945.22 | 537.28 | 734.45 | 673.85 | 746.55 |
Long-Term Leases | 76.25 | 80.09 | 94.57 | 0.02 | 1.54 | - |
Long-Term Unearned Revenue | 126.52 | 128.37 | 101.95 | 91.66 | 94.41 | 43.35 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.38 | - |
Other Long-Term Liabilities | - | - | - | - | - | 4.88 |
Total Liabilities | 3,693 | 3,591 | 3,411 | 3,758 | 3,531 | 2,681 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 438.41 | 438.41 | 438.41 | 342.51 | 342.91 | 245.02 |
Additional Paid-In Capital | 1,647 | 1,647 | 1,643 | 810.74 | 813.79 | 1,141 |
Retained Earnings | 494.63 | 473.68 | 529.21 | 600.23 | 624.25 | 822.53 |
Treasury Stock | - | - | - | - | -24.64 | -27.75 |
Comprehensive Income & Other | -4.81 | -1.06 | 17.46 | -0.88 | 8.93 | -5.51 |
Total Common Equity | 2,575 | 2,558 | 2,628 | 1,753 | 1,765 | 2,175 |
Minority Interest | 6.2 | 6.34 | 6.29 | 6.3 | 5.97 | 39.56 |
Shareholders' Equity | 2,581 | 2,564 | 2,634 | 1,759 | 1,771 | 2,215 |
Total Liabilities & Equity | 6,274 | 6,155 | 6,046 | 5,516 | 5,302 | 4,895 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,043 | 2,966 | 2,659 | 3,056 | 2,782 | 1,908 |
Net Cash (Debt) | -2,735 | -2,550 | -2,056 | -2,491 | -2,120 | -1,062 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -5.51 | -4.99 | -5.02 | -7.32 | -6.15 | -3.08 |
Filing Date Shares Outstanding | 438.41 | 438.41 | 438.41 | 342.51 | 342.4 | 342.15 |
Total Common Shares Outstanding | 438.41 | 438.41 | 438.41 | 342.51 | 342.4 | 342.15 |
Working Capital | 53.61 | -165.8 | -446.72 | -666.63 | -588.15 | 175.75 |
Book Value Per Share | 5.87 | 5.83 | 5.99 | 5.12 | 5.16 | 6.36 |
Tangible Book Value | 1,884 | 1,863 | 1,921 | 1,036 | 1,050 | 1,424 |
Tangible Book Value Per Share | 4.30 | 4.25 | 4.38 | 3.02 | 3.07 | 4.16 |
Buildings | - | 1,646 | 1,286 | 1,174 | 1,018 | 951.68 |
Machinery | - | 2,097 | 1,915 | 1,739 | 124.38 | 1,254 |
Construction In Progress | - | 659.53 | 871.31 | 453.09 | 635.52 | 371.47 |